$86.63-0.75 (-0.86%)
News0/Ratings0
Price$86.63+4.30 (+5.22%)
2026-01-212026-04-24
Latest news
0 itemsNo recent news.
BBP FAQ
6 questionsWhat does Virtus LifeSci Biotech Products ETF do?
The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.Where does BBP stock trade?
Virtus LifeSci Biotech Products ETF (BBP) is listed on NASDAQ.What sector and industry is BBP in?
Virtus LifeSci Biotech Products ETF operates in the n/a sector.When did Virtus LifeSci Biotech Products ETF go public?
Virtus LifeSci Biotech Products ETF (BBP) completed its IPO in n/a.What companies are similar to BBP?
Notable peers in the same industry include CBOE (Cboe Global Markets, Inc.), HCXY (Hercules Capital, Inc.), PCI (PIMCO Dynamic Credit and Mortgage Income Fund), BXS (BancorpSouth Bank), AJAX (Ajax I). Compare BBP side-by-side with any of them on Quantisnow.How can I track BBP on Quantisnow?
Quantisnow aggregates Virtus LifeSci Biotech Products ETF's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BBP to receive live email and push alerts on every new disclosure.